Health Canada

Fact Sheet on Biosimilars

Canadian Agency for Drugs and Technologies in Health (CADTH)

Biosimilar Drugs: Your Questions Answered

CADTH Backgrounder on Biosimilars for Health Care Providers

Ontario Health/Leslie Dan Faculty of Pharmacy, University of Toronto

Massive Open Online Course (MOOC) on Biosimilar Biologics

Canadian Institute for Health Information

Prescribed Drug Spending in Canada, 2020: A Focus on Public Drug Programs. Ottawa, ON: CIHI; 2020. https://www.cihi.ca/en/public-spending-on-prescribed-drugs-in-canada-in-2020

Patented Medicines Prices Review Board

Potential Savings from Biosimilars in Canada

Ontario Drug Policy Research Network

Current and Prospective Utilization of Innovator Biologics and Biosimilars in Ontario 

pan-Canadian Pharmaceutical Alliance / Cancer Care Ontario

Pan-Canadian Oncology Biosimilars Initiative

Pan-Canadian Oncology Biosimilars Initiative Action Plan

Pan-Canadian Oncology Biosimilars Summit Proceedings Report

International Coalition of Medicines Regulatory Authorities (ICMRA) statement about confidence in biosimilar products

European Medicines Agency and The European Commission: Biosimilars in the EU: Information Guide for Healthcare Professionals

European Medicines Agency: Biosimilars Medicines: Overview

FDA Biosimilars Home Page